152 related articles for article (PubMed ID: 30359249)
41. An IL6-correlated signature in serous epithelial ovarian cancer associates with growth factor response.
Pinciroli P; Alberti C; Sensi M; Canevari S; Tomassetti A
BMC Genomics; 2013 Jul; 14():508. PubMed ID: 23889749
[TBL] [Abstract][Full Text] [Related]
42. Conditional disease-free survival rates and their associated determinants in patients with epithelial ovarian cancer: A 15-year retrospective cohort study.
Ebrahimi V; Khalafi-Nezhad A; Ahmadpour F; Jowkar Z
Cancer Rep (Hoboken); 2021 Dec; 4(6):e1416. PubMed ID: 33949809
[TBL] [Abstract][Full Text] [Related]
43. Residential segregation and overall survival of women with epithelial ovarian cancer.
Westrick AC; Bailey ZD; Schlumbrecht M; Hlaing WM; Kobetz EE; Feaster DJ; Balise RR
Cancer; 2020 Aug; 126(16):3698-3707. PubMed ID: 32484923
[TBL] [Abstract][Full Text] [Related]
44. High grade, advanced, serous ovarian cancer with low serum CA125 levels.
Asali A; Haj-Yehia N; Zehavi T; Perry T; Beiner M; Fishman A; Kadan Y
J Obstet Gynaecol; 2021 Oct; 41(7):1107-1111. PubMed ID: 33427544
[TBL] [Abstract][Full Text] [Related]
45. Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.
Wang B; Wang S; Ren W
BMC Cancer; 2021 May; 21(1):609. PubMed ID: 34034697
[TBL] [Abstract][Full Text] [Related]
46. [Can new molecular profiles in epithelial ovarian cancer modify therapeutics?].
Lavoué V; Rousselin A; Delplanque S; Pinsard M; Henno S; Foucher F; Levêque J; de la Motte Rouge T
J Gynecol Obstet Hum Reprod; 2017 Feb; 46(2):107-112. PubMed ID: 28403964
[TBL] [Abstract][Full Text] [Related]
47. Development and validation of nomograms for epithelial ovarian cancer: a SEER population-based, real-world study.
Wang R; Xie G; Shang L; Qi C; Yang L; Huang L; Li D; Yang W
Future Oncol; 2021 Mar; 17(8):893-906. PubMed ID: 33533669
[No Abstract] [Full Text] [Related]
48. Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysis.
Le Page C; Rahimi K; Rodrigues M; Heinzelmann-Schwarz V; Recio N; Tommasi S; Bataillon G; Portelance L; Golmard L; Meunier L; Tonin PN; Gotlieb W; Yasmeen A; Ray-Coquard I; Labidi-Galy SI; Provencher D; Mes-Masson AM
Gynecol Oncol; 2020 Feb; 156(2):377-386. PubMed ID: 31753525
[TBL] [Abstract][Full Text] [Related]
49. A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention.
Hanley GE; McAlpine JN; Miller D; Huntsman D; Schrader KA; Blake Gilks C; Mitchell G
BMC Cancer; 2018 Mar; 18(1):254. PubMed ID: 29506471
[TBL] [Abstract][Full Text] [Related]
50. Adult lifetime alcohol consumption and invasive epithelial ovarian cancer risk in a population-based case-control study.
Cook LS; Leung AC; Swenerton K; Gallagher RP; Magliocco A; Steed H; Koebel M; Nation J; Eshragh S; Brooks-Wilson A; Le ND
Gynecol Oncol; 2016 Feb; 140(2):277-84. PubMed ID: 26691218
[TBL] [Abstract][Full Text] [Related]
51. BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groups.
Safra T; Lai WC; Borgato L; Nicoletto MO; Berman T; Reich E; Alvear M; Haviv I; Muggia FM
Ann Oncol; 2013 Nov; 24 Suppl 8():viii63-viii68. PubMed ID: 24131973
[TBL] [Abstract][Full Text] [Related]
52. Chemotherapy Toxicity in
Weitzner O; Yagur Y; Kadan Y; Beiner ME; Fishman A; Ben Ezry E; Amitai Komem D; Helpman L
Oncologist; 2019 Dec; 24(12):e1471-e1475. PubMed ID: 31346131
[TBL] [Abstract][Full Text] [Related]
53. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
[TBL] [Abstract][Full Text] [Related]
54. Characterization of ovarian cancer survival by histotype and stage: A nationwide study in Norway.
Fortner RT; Trewin-Nybråten CB; Paulsen T; Langseth H
Int J Cancer; 2023 Sep; 153(5):969-978. PubMed ID: 37226635
[TBL] [Abstract][Full Text] [Related]
55. The correlation between BRCA status and surgical cytoreduction in high-grade serous ovarian carcinoma.
Kim SR; Malcolmson J; Li X; Bernardini MQ; Hogen L; May T
Gynecol Oncol; 2021 Sep; 162(3):702-706. PubMed ID: 34256977
[TBL] [Abstract][Full Text] [Related]
56. Genetic variants and expression of the TIM-3 gene are associated with clinical prognosis in patients with epithelial ovarian cancer.
Wu JL; Zhao J; Zhang HB; Zuo WW; Li Y; Kang S
Gynecol Oncol; 2020 Oct; 159(1):270-276. PubMed ID: 32694063
[TBL] [Abstract][Full Text] [Related]
57. Differences between complex epithelial neoplasms of the ovary and high-grade serous ovarian cancer: a retrospective observational cohort study.
Li X; Ding Y; Liu Y; Yang M
J Ovarian Res; 2022 Dec; 15(1):125. PubMed ID: 36456989
[TBL] [Abstract][Full Text] [Related]
58. A multi-level investigation of the genetic relationship between endometriosis and ovarian cancer histotypes.
Mortlock S; Corona RI; Kho PF; Pharoah P; Seo JH; Freedman ML; Gayther SA; Siedhoff MT; Rogers PAW; Leuchter R; Walsh CS; Cass I; Karlan BY; Rimel BJ; ; Montgomery GW; Lawrenson K; Kar SP
Cell Rep Med; 2022 Mar; 3(3):100542. PubMed ID: 35492879
[TBL] [Abstract][Full Text] [Related]
59. Transcriptional Characterization of Stage I Epithelial Ovarian Cancer: A Multicentric Study.
Calura E; Ciciani M; Sambugaro A; Paracchini L; Benvenuto G; Milite S; Martini P; Beltrame L; Zane F; Fruscio R; Marchette MD; Borella F; Tognon G; Ravaggi A; Katsaros D; Bignotti E; Odicino F; D'Incalci M; Marchini S; Romualdi C
Cells; 2019 Dec; 8(12):. PubMed ID: 31805750
[TBL] [Abstract][Full Text] [Related]
60. Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint study.
Machida H; Matsuo K; Yamagami W; Ebina Y; Kobayashi Y; Tabata T; Kanauchi M; Nagase S; Enomoto T; Mikami M
Gynecol Oncol; 2019 Jun; 153(3):589-596. PubMed ID: 30905436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
